The regulatory framework for transplantation in the United States is governed by the Organ Procurement and Transplant Network (OPTN), a federally established process that is managed by an independent contractor. A component of the guidance of the OPTN is that transplant centers and organ procurement organizations (OPOs) will be subject to transparent and recurring analysis of their individual performance. With a continued disparity between the supply and the demand of transplantable organs, the systems established to evaluate performance must critically assess where opportunities for improvement exist.
Gerber DA, Chapman WC. The Current Opaque State of Organ Donation Metrics in the United States. JAMA Surg. 2021;156(2):180. doi:10.1001/jamasurg.2020.5396
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.